Search

everythinglearnresearchcommunity

for

Search:↓

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Alopecia mucinosa can be treated successfully with minocycline.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

HIV can cause various severe or unusual skin conditions that help indicate the presence and stage of the disease.

FMF and mycosis fungoides are variants of the same disease, and bexarotene can be an effective treatment.

New treatments and understanding of skin lupus are emerging in 2024.

Skin conditions in multiple myeloma patients vary with the timing of bone marrow transplants.

An 8-year-old girl had a rare, benign skin tumor on her forehead.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Alopecia mucinosa on the face can be linked to mycosis fungoides, a type of lymphoma.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Benign follicular mucinosis involves immune cells attacking hair follicles.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.